APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immunology Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Immunology Drug Industry Growth and Trends Forecast to 2032

20 December 2025105 pages

Choose your research edition.

Industry ResearchImmunology Drug Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Immunology Drug Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Immunology Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immunology Drug Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Immunology Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Immunology Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Immunology Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Immunology Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Immunology Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Immunology Drug include Eisai Co., Eli Lilly and Company, Pfizer, GlaxoSmithKline plc, Bayer AG, Seattle Genetics, Sanofi Aventis LLC., Genentech and F. Hoffmann-La Roche Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Immunology Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Immunology Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Immunology Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Immunology Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Immunology Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Immunology Drug Market by Company

Eisai Co.

Eli Lilly and Company

Pfizer

GlaxoSmithKline plc

Bayer AG

Seattle Genetics

Sanofi Aventis LLC.

Genentech

F. Hoffmann-La Roche Ltd.

Autoimmune Inc.

Active Biotech

Abbott Laboratories

Immunology Drug Segment by Type

Monoclonal Antibodies (mAb)

Antibody Drug Conjugates

Immunosuppressive medication

Others

Immunology Drug Segment by Application

Cancer Research Centers and Institutes

Hospitals

Clinics

Immunology Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunology Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immunology Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunology Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Immunology Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Immunology Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Monoclonal Antibodies (mAb) Table 2. Major Company of Antibody Drug Conjugates Table 3. Major Company of Immunosuppressive medication Table 4. Major Company of Others Table 5. Global Immunology Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Immunology Drug Sales by Type (2021-2026) & (K Units) Table 7. Global Immunology Drug Sales Market Share in Volume by Type (2021-2026) Table 8. Global Immunology Drug Sales by Type (2021-2026) & (US$ Million) Table 9. Global Immunology Drug Sales Market Share in Value by Type (2021-2026) Table 10. Global Immunology Drug Price by Type (2021-2026) & (US$/Unit) Table 11. Global Immunology Drug Sales by Type (2027-2032) & (K Units) Table 12. Global Immunology Drug Sales Market Share in Volume by Type (2027-2032) Table 13. Global Immunology Drug Sales by Type (2027-2032) & (US$ Million) Table 14. Global Immunology Drug Sales Market Share in Value by Type (2027-2032) Table 15. Global Immunology Drug Price by Type (2027-2032) & (US$/Unit) Table 16. North America Immunology Drug Sales by Type (2021-2026) & (K Units) Table 17. North America Immunology Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Immunology Drug Sales by Type (2021-2026) & (K Units) Table 19. Europe Immunology Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Immunology Drug Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Immunology Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Immunology Drug Sales by Type (2021-2026) & (K Units) Table 23. Latin America Immunology Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Immunology Drug Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Immunology Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Immunology Drug Industry Trends Table 27. Immunology Drug Industry Drivers Table 28. Immunology Drug Industry Opportunities and Challenges Table 29. Immunology Drug Industry Restraints Table 30. Global Immunology Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Immunology Drug Revenue Market Share by Company (2021-2026) Table 32. Global Immunology Drug Sales by Company (2021-2026) & (K Units) Table 33. Global Immunology Drug Sales Share by Company (2021-2026) Table 34. Global Immunology Drug Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Immunology Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Immunology Drug Major Company Production Sites and Headquarters Table 37. Global Immunology Drug Company, Product Type & Application Table 38. Global Immunology Drug Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Immunology Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Immunology Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Immunology Drug Sales by Region (2021-2026) & (K Units) Table 43. Global Immunology Drug Sales Market Share in Volume by Region (2021-2026) Table 44. Global Immunology Drug Sales by Region (2021-2026) & (US$ Million) Table 45. Global Immunology Drug Sales Market Share in Value by Region (2021-2026) Table 46. Global Immunology Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Immunology Drug Sales by Region (2027-2032) & (K Units) Table 48. Global Immunology Drug Sales Market Share in Volume by Region (2027-2032) Table 49. Global Immunology Drug Sales by Region (2027-2032) & (US$ Million) Table 50. Global Immunology Drug Sales Market Share in Value by Region (2027-2032) Table 51. Global Immunology Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Immunology Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Immunology Drug Sales by Application (2021-2026) & (K Units) Table 54. Global Immunology Drug Sales Market Share in Volume by Application (2021-2026) Table 55. Global Immunology Drug Sales by Application (2021-2026) & (US$ Million) Table 56. Global Immunology Drug Sales Market Share in Value by Application (2021-2026) Table 57. Global Immunology Drug Price by Application (2021-2026) & (US$/Unit) Table 58. Global Immunology Drug Sales by Application (2027-2032) & (K Units) Table 59. Global Immunology Drug Sales Market Share in Volume by Application (2027-2032) Table 60. Global Immunology Drug Sales by Application (2027-2032) & (US$ Million) Table 61. Global Immunology Drug Sales Market Share in Value by Application (2027-2032) Table 62. Global Immunology Drug Price by Application (2027-2032) & (US$/Unit) Table 63. North America Immunology Drug Sales by Application (2021-2026) & (K Units) Table 64. North America Immunology Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Immunology Drug Sales by Application (2021-2026) & (K Units) Table 66. Europe Immunology Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Immunology Drug Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Immunology Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Immunology Drug Sales by Application (2021-2026) & (K Units) Table 70. Latin America Immunology Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Immunology Drug Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Immunology Drug Sales by Application (2021-2026) & (US$ Million) Table 73. Eisai Co. Company Information Table 74. Eisai Co. Business Overview Table 75. Eisai Co. Immunology Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Eisai Co. Immunology Drug Product Portfolio Table 77. Eisai Co. Recent Development Table 78. Eli Lilly and Company Company Information Table 79. Eli Lilly and Company Business Overview Table 80. Eli Lilly and Company Immunology Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Eli Lilly and Company Immunology Drug Product Portfolio Table 82. Eli Lilly and Company Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Immunology Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Pfizer Immunology Drug Product Portfolio Table 87. Pfizer Recent Development Table 88. GlaxoSmithKline plc Company Information Table 89. GlaxoSmithKline plc Business Overview Table 90. GlaxoSmithKline plc Immunology Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. GlaxoSmithKline plc Immunology Drug Product Portfolio Table 92. GlaxoSmithKline plc Recent Development Table 93. Bayer AG Company Information Table 94. Bayer AG Business Overview Table 95. Bayer AG Immunology Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Bayer AG Immunology Drug Product Portfolio Table 97. Bayer AG Recent Development Table 98. Seattle Genetics Company Information Table 99. Seattle Genetics Business Overview Table 100. Seattle Genetics Immunology Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Seattle Genetics Immunology Drug Product Portfolio Table 102. Seattle Genetics Recent Development Table 103. Sanofi Aventis LLC. Company Information Table 104. Sanofi Aventis LLC. Business Overview Table 105. Sanofi Aventis LLC. Immunology Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Sanofi Aventis LLC. Immunology Drug Product Portfolio Table 107. Sanofi Aventis LLC. Recent Development Table 108. Genentech Company Information Table 109. Genentech Business Overview Table 110. Genentech Immunology Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Genentech Immunology Drug Product Portfolio Table 112. Genentech Recent Development Table 113. F. Hoffmann-La Roche Ltd. Company Information Table 114. F. Hoffmann-La Roche Ltd. Business Overview Table 115. F. Hoffmann-La Roche Ltd. Immunology Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. F. Hoffmann-La Roche Ltd. Immunology Drug Product Portfolio Table 117. F. Hoffmann-La Roche Ltd. Recent Development Table 118. Autoimmune Inc. Company Information Table 119. Autoimmune Inc. Business Overview Table 120. Autoimmune Inc. Immunology Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Autoimmune Inc. Immunology Drug Product Portfolio Table 122. Autoimmune Inc. Recent Development Table 123. Active Biotech Company Information Table 124. Active Biotech Business Overview Table 125. Active Biotech Immunology Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Active Biotech Immunology Drug Product Portfolio Table 127. Active Biotech Recent Development Table 128. Abbott Laboratories Company Information Table 129. Abbott Laboratories Business Overview Table 130. Abbott Laboratories Immunology Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Abbott Laboratories Immunology Drug Product Portfolio Table 132. Abbott Laboratories Recent Development Table 133. North America Immunology Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. North America Immunology Drug Sales by Country (2021-2026) & (K Units) Table 135. North America Immunology Drug Sales Market Share by Country (2021-2026) Table 136. North America Immunology Drug Sales Forecast by Country (2027-2032) & (K Units) Table 137. North America Immunology Drug Sales Market Share Forecast by Country (2027-2032) Table 138. North America Immunology Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Immunology Drug Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Immunology Drug Market Share by Country (2021-2026) Table 141. North America Immunology Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Immunology Drug Market Share Forecast by Country (2027-2032) Table 143. Europe Immunology Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Europe Immunology Drug Sales by Country (2021-2026) & (K Units) Table 145. Europe Immunology Drug Sales Market Share by Country (2021-2026) Table 146. Europe Immunology Drug Sales Forecast by Country (2027-2032) & (K Units) Table 147. Europe Immunology Drug Sales Market Share Forecast by Country (2027-2032) Table 148. Europe Immunology Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe Immunology Drug Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe Immunology Drug Market Share by Country (2021-2026) Table 151. Europe Immunology Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe Immunology Drug Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Immunology Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Immunology Drug Sales by Country (2021-2026) & (K Units) Table 155. Asia-Pacific Immunology Drug Sales Market Share by Country (2021-2026) Table 156. Asia-Pacific Immunology Drug Sales Forecast by Country (2027-2032) & (K Units) Table 157. Asia-Pacific Immunology Drug Sales Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Immunology Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Immunology Drug Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Immunology Drug Market Share by Country (2021-2026) Table 161. Asia-Pacific Immunology Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Immunology Drug Market Share Forecast by Country (2027-2032) Table 163. Latin America Immunology Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 164. Latin America Immunology Drug Sales by Country (2021-2026) & (K Units) Table 165. Latin America Immunology Drug Sales Market Share by Country (2021-2026) Table 166. Latin America Immunology Drug Sales Forecast by Country (2027-2032) & (K Units) Table 167. Latin America Immunology Drug Sales Market Share Forecast by Country (2027-2032) Table 168. Latin America Immunology Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America Immunology Drug Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America Immunology Drug Market Share by Country (2021-2026) Table 171. Latin America Immunology Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America Immunology Drug Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa Immunology Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa Immunology Drug Sales by Country (2021-2026) & (K Units) Table 175. Middle East and Africa Immunology Drug Sales Market Share by Country (2021-2026) Table 176. Middle East and Africa Immunology Drug Sales Forecast by Country (2027-2032) & (K Units) Table 177. Middle East and Africa Immunology Drug Sales Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa Immunology Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa Immunology Drug Market Size by Country (2021-2026) & (US$ Million) Table 180. Middle East and Africa Immunology Drug Market Share by Country (2021-2026) Table 181. Middle East and Africa Immunology Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Middle East and Africa Immunology Drug Market Share Forecast by Country (2027-2032) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Immunology Drug Distributors List Table 186. Immunology Drug Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Immunology Drug Image Figure 2. Global Immunology Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immunology Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Immunology Drug Sales (2021-2032) & (K Units) Figure 5. Monoclonal Antibodies (mAb) Image Figure 6. Global Monoclonal Antibodies (mAb) Sales YoY Growth (2021-2032) & (K Units) Figure 7. Antibody Drug Conjugates Image Figure 8. Global Antibody Drug Conjugates Sales YoY Growth (2021-2032) & (K Units) Figure 9. Immunosuppressive medication Image Figure 10. Global Immunosuppressive medication Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Immunology Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Immunology Drug Market Share by Type 2025 VS 2032 Figure 15. North America Immunology Drug Sales Market Share in Volume by Type in 2025 Figure 16. North America Immunology Drug Sales Market Share in Value by Type in 2025 Figure 17. Europe Immunology Drug Sales Market Share in Volume by Type in 2025 Figure 18. Europe Immunology Drug Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Immunology Drug Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Immunology Drug Sales Market Share in Value by Type in 2025 Figure 21. Latin America Immunology Drug Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Immunology Drug Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Immunology Drug Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Immunology Drug Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Immunology Drug Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Cancer Research Centers and Institutes Image Figure 28. Global Cancer Research Centers and Institutes Sales YoY Growth (2021-2032) & (K Units) Figure 29. Hospitals Image Figure 30. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 31. Clinics Image Figure 32. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Immunology Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Immunology Drug Market Share by Application 2025 VS 2032 Figure 35. North America Immunology Drug Sales Market Share in Volume by Application in 2025 Figure 36. North America Immunology Drug Sales Market Share in Value by Application in 2025 Figure 37. Europe Immunology Drug Sales Market Share in Volume by Application in 2025 Figure 38. Europe Immunology Drug Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Immunology Drug Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Immunology Drug Sales Market Share in Value by Application in 2025 Figure 41. Latin America Immunology Drug Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Immunology Drug Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Immunology Drug Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Immunology Drug Sales Market Share in Value by Application in 2025 Figure 45. North America Immunology Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Immunology Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Immunology Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Immunology Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Immunology Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Immunology Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Immunology Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Immunology Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Immunology Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Immunology Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Immunology Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Immunology Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Immunology Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Immunology Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Immunology Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Immunology Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Immunology Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Immunology Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Immunology Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Immunology Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Immunology Drug Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Immunology Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Monoclonal Antibodies (mAb)
  • Antibody Drug Conjugates
  • Immunosuppressive medication
  • Others
Applications
  • Cancer Research Centers and Institutes
  • Hospitals
  • Clinics
Companies covered
  • Eisai Co.
  • Eli Lilly and Company
  • Pfizer
  • GlaxoSmithKline plc
  • Bayer AG
  • Seattle Genetics
  • Sanofi Aventis LLC.
  • Genentech
  • F. Hoffmann-La Roche Ltd.
  • Autoimmune Inc.
  • Active Biotech
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Immunology Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Immunology Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Immunology Drug Market by Type
  6. 1.3.1 Monoclonal Antibodies (mAb)
  7. 1.3.2 Antibody Drug Conjugates
  8. 1.3.3 Immunosuppressive medication
  9. 1.3.4 Others
  10. 1.4 Global Immunology Drug Market Size by Type
  11. 1.4.1 Global Immunology Drug Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Immunology Drug Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Immunology Drug Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Immunology Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Immunology Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Immunology Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Immunology Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Immunology Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Immunology Drug Industry Trends
  2. 2.2 Immunology Drug Industry Drivers
  3. 2.3 Immunology Drug Industry Opportunities and Challenges
  4. 2.4 Immunology Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Immunology Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Immunology Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Immunology Drug Price (2021-2026)
  4. 3.4 Global Immunology Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Immunology Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Immunology Drug Company, Product Type & Application
  7. 3.7 Global Immunology Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Immunology Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Immunology Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Immunology Drug Tier 1, Tier 2, and Tier 3
4 Immunology Drug Regional Status and Outlook
  1. 4.1 Global Immunology Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Immunology Drug Historic Market Size by Region
  3. 4.2.1 Global Immunology Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Immunology Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Immunology Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Immunology Drug Forecasted Market Size by Region
  7. 4.3.1 Global Immunology Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Immunology Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Immunology Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Immunology Drug by Application
  1. 5.1 Immunology Drug Market by Application
  2. 5.1.1 Cancer Research Centers and Institutes
  3. 5.1.2 Hospitals
  4. 5.1.3 Clinics
  5. 5.2 Global Immunology Drug Market Size by Application
  6. 5.2.1 Global Immunology Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Immunology Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Immunology Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Immunology Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Immunology Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Immunology Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Immunology Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Immunology Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Eisai Co.
  2. 6.1.1 Eisai Co. Company Information
  3. 6.1.2 Eisai Co. Business Overview
  4. 6.1.3 Eisai Co. Immunology Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Eisai Co. Immunology Drug Product Portfolio
  6. 6.1.5 Eisai Co. Recent Developments
  7. 6.2 Eli Lilly and Company
  8. 6.2.1 Eli Lilly and Company Company Information
  9. 6.2.2 Eli Lilly and Company Business Overview
  10. 6.2.3 Eli Lilly and Company Immunology Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Eli Lilly and Company Immunology Drug Product Portfolio
  12. 6.2.5 Eli Lilly and Company Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Immunology Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Immunology Drug Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 GlaxoSmithKline plc
  20. 6.4.1 GlaxoSmithKline plc Company Information
  21. 6.4.2 GlaxoSmithKline plc Business Overview
  22. 6.4.3 GlaxoSmithKline plc Immunology Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GlaxoSmithKline plc Immunology Drug Product Portfolio
  24. 6.4.5 GlaxoSmithKline plc Recent Developments
  25. 6.5 Bayer AG
  26. 6.5.1 Bayer AG Company Information
  27. 6.5.2 Bayer AG Business Overview
  28. 6.5.3 Bayer AG Immunology Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bayer AG Immunology Drug Product Portfolio
  30. 6.5.5 Bayer AG Recent Developments
  31. 6.6 Seattle Genetics
  32. 6.6.1 Seattle Genetics Company Information
  33. 6.6.2 Seattle Genetics Business Overview
  34. 6.6.3 Seattle Genetics Immunology Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Seattle Genetics Immunology Drug Product Portfolio
  36. 6.6.5 Seattle Genetics Recent Developments
  37. 6.7 Sanofi Aventis LLC.
  38. 6.7.1 Sanofi Aventis LLC. Company Information
  39. 6.7.2 Sanofi Aventis LLC. Business Overview
  40. 6.7.3 Sanofi Aventis LLC. Immunology Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sanofi Aventis LLC. Immunology Drug Product Portfolio
  42. 6.7.5 Sanofi Aventis LLC. Recent Developments
  43. 6.8 Genentech
  44. 6.8.1 Genentech Company Information
  45. 6.8.2 Genentech Business Overview
  46. 6.8.3 Genentech Immunology Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Genentech Immunology Drug Product Portfolio
  48. 6.8.5 Genentech Recent Developments
  49. 6.9 F. Hoffmann-La Roche Ltd.
  50. 6.9.1 F. Hoffmann-La Roche Ltd. Company Information
  51. 6.9.2 F. Hoffmann-La Roche Ltd. Business Overview
  52. 6.9.3 F. Hoffmann-La Roche Ltd. Immunology Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 F. Hoffmann-La Roche Ltd. Immunology Drug Product Portfolio
  54. 6.9.5 F. Hoffmann-La Roche Ltd. Recent Developments
  55. 6.10 Autoimmune Inc.
  56. 6.10.1 Autoimmune Inc. Company Information
  57. 6.10.2 Autoimmune Inc. Business Overview
  58. 6.10.3 Autoimmune Inc. Immunology Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Autoimmune Inc. Immunology Drug Product Portfolio
  60. 6.10.5 Autoimmune Inc. Recent Developments
  61. 6.11 Active Biotech
  62. 6.11.1 Active Biotech Company Information
  63. 6.11.2 Active Biotech Business Overview
  64. 6.11.3 Active Biotech Immunology Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Active Biotech Immunology Drug Product Portfolio
  66. 6.11.5 Active Biotech Recent Developments
  67. 6.12 Abbott Laboratories
  68. 6.12.1 Abbott Laboratories Company Information
  69. 6.12.2 Abbott Laboratories Business Overview
  70. 6.12.3 Abbott Laboratories Immunology Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Abbott Laboratories Immunology Drug Product Portfolio
  72. 6.12.5 Abbott Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America Immunology Drug Sales by Country
  2. 7.1.1 North America Immunology Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Immunology Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Immunology Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Immunology Drug Market Size by Country
  6. 7.2.1 North America Immunology Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Immunology Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Immunology Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Immunology Drug Sales by Country
  2. 8.1.1 Europe Immunology Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Immunology Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Immunology Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Immunology Drug Market Size by Country
  6. 8.2.1 Europe Immunology Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Immunology Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Immunology Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Immunology Drug Sales by Country
  2. 9.1.1 Asia-Pacific Immunology Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Immunology Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Immunology Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Immunology Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Immunology Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Immunology Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Immunology Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Immunology Drug Sales by Country
  2. 10.1.1 South America Immunology Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Immunology Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Immunology Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Immunology Drug Market Size by Country
  6. 10.2.1 South America Immunology Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Immunology Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Immunology Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Immunology Drug Sales by Country
  2. 11.1.1 Middle East and Africa Immunology Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Immunology Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Immunology Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Immunology Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Immunology Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Immunology Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Immunology Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Immunology Drug Value Chain Analysis
  2. 12.1.1 Immunology Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Immunology Drug Production Mode & Process
  7. 12.2 Immunology Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Immunology Drug Distributors
  10. 12.2.3 Immunology Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst